Collegium Pharmaceutical Inc (COLL)

[floblu14]

Disclosure - as a former, LUCKY shareholder of MOMENTA PHARMACEUTICALS, I am now an official Collegium. Also, big into REVANCE THERAPEUTICS - RVNC.

Here's some great COLL news -

29 December:
Needham names Collegium Pharma Top Pick for 2021, adds to Conviction List 07:35 COLL, RVNC Needham analyst Serge Belanger named Collegium Pharmaceutical (COLL) as his 2021 best idea and added the company to Needham Conviction List in place of Revance Therapeutics (RVNC), which was removed. The analyst is also keeping his Buy rating and $34 price target on Collegium. Belanger states that the growth prospects of the company's Xtampza within the "complex" opioid market remains its "key value driver" with significant sales growth expected next year, but the investment story has grown to include its "stabilized" Nucynta franchise. The analyst believes that Nucynta could contribute to Collegium's top-line growth and a "leverageable" cost structure that will further improve the company's profitability and cash generation.

Read more at:
https://thefly.com/n.php?id=3218629

Regards,

FLO